265 results on '"Diamant, Zuzana"'
Search Results
2. An Update on Patient-Reported Outcomes in Asthma
3. A EUFOREA comment on a lost comorbidity of asthma
4. Mepolizumab improvements in health-related quality of life and disease symptoms in a patient population with very severe chronic rhinosinusitis with nasal polyps: psychometric and efficacy analyses from the SYNAPSE study
5. Biologics in severe asthma: A pragmatic approach for choosing the right treatment for the right patient
6. Asthma in the era of COVID-19
7. EUFOREA pocket guide on the diagnosis and management of asthma: An educational and practical tool for general practitioners, non-respiratory physicians, paramedics and patients
8. Dysfunctional mucociliary clearance in asthma and airway remodeling – New insights into an old topic
9. Allergen immunotherapy for allergic asthma: The future seems bright
10. Chronic Rhinosinusitis Outcome Registry (CHRINOSOR): Establishment of an International Outcome Registry Driven by mHealth Technology
11. Digital tools in allergy and respiratory care
12. Plasma proteome changes linked to late phase response after inhaled allergen challenge in asthmatics
13. Lung Function Normalisation with Indacaterol Acetate/Glycopyrronium Bromide/Mometasone Furoate in Patients with Asthma
14. EUFOREA/EPOS2020 statement on the clinical considerations for chronic rhinosinusitis with nasal polyps care.
15. Research Priorities in Pediatric Asthma: Results of a Global Survey of Multiple Stakeholder Groups by the Pediatric Asthma in Real Life (PeARL) Think Tank
16. First-in-Man Safety, Tolerability, and Pharmacokinetics of a Novel and Highly Selective Inhibitor of Matrix Metalloproteinase-12, FP-025: Results from Two Randomized Studies in Healthy Subjects
17. Evaluating treatment response to mepolizumab in patients with severe CRSwNP*
18. Towards precision medicine in severe asthma: Treatment algorithms based on treatable traits
19. Asthma: a modifiable disease on a crossroad
20. Asthma and severe acute respiratory syndrome coronavirus 2019: current evidence and knowledge gaps
21. Allergen bronchoprovocation test: an important research tool supporting precision medicine
22. Revisiting matrix metalloproteinase 12: its role in pathophysiology of asthma and related pulmonary diseases
23. Editorial: Dealing with asthma during the turbulent times of coronavirus disease-2019
24. Letter to the editor: indacaterol/glycopyrronium/mometasone furoate compared with salmeterol/fluticasone propionate in patients with asthma: a randomized controlled cross-over study
25. Sustained efficacy of mepolizumab in patients with severe chronic rhinosinusitis with nasal polyps: SYNAPSE 24‐week treatment‐free follow‐up.
26. Eosinophils—from cradle to grave: An EAACI task force paper on new molecular insights and clinical functions of eosinophils and the clinical effects of targeted eosinophil depletion.
27. Standardization of clinical outcomes used in allergen immunotherapy in allergic asthma: An EAACI position paper.
28. A EUFOREA comment on a lost comorbidity of asthma
29. Precision medicine and treatable traits in chronic airway diseases - where do we stand?
30. Effects of low- versus high-dose fluticasone propionate/formoterol fumarate combination therapy on AMP challenge in asthmatic patients: A double-blind, randomised clinical trial
31. Targeting lipid mediators in asthma: time for reappraisal
32. Editorial introductions
33. Reproducibility of biomarkers in induced sputum and in serum from chronic smokers
34. Effects of non-steroidal anti-inflammatory drugs and other eicosanoid pathway modifiers on antiviral and allergic responses: EAACI task force on eicosanoids consensus report in times of COVID-19
35. Assessing patient-reported outcomes in asthma and COPD patients: which can be recommended in clinical practice?
36. Targeting the interleukin-4 and interleukin-13 pathways in severe asthma: current knowledge and future needs
37. The road to precision medicine in asthma: challenges and opportunities
38. New insights into the pathophysiology and therapeutic targets of asthma and comorbid chronic rhinosinusitis with or without nasal polyposis.
39. Impact of dupilumab on SNOT-22 sleep and function scores in CRSwNP
40. Role of biologics targeting type 2 airway inflammation in asthma: what have we learned so far?
41. Generic medications in precision medicine in asthma
42. Efficacy of FP‐025: A novel matrix metalloproteinase‐12 (MMP‐12) inhibitor in murine allergic asthma.
43. Can a Single Dose Response Predict the Effect of Montelukast on Exercise-Induced Bronchoconstriction?
44. Neutrophil phenotypes in bronchial airways differentiate single from dual responding allergic asthmatics.
45. Study protocol of a systematic evidence update by the Paediatric Asthma in Real Life (PeARL) Think Tank
46. Guest Editor's bio: Dr. Zuzana Diamant
47. Physical exercise, immune response, and susceptibility to infections—current knowledge and growing research areas.
48. Single- and multiple-dose tolerability and pharmacokinetics of the CRTH2 antagonist setipiprant in healthy male subjects
49. Childhood asthma outcomes during the COVID-19 pandemic: Findings from the PeARL multi-national cohort
50. Management of asthma in childhood: study protocol of a systematic evidence update by the Paediatric Asthma in Real Life (PeARL) Think Tank
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.